Novartis unit Sandoz has won its bid to stay a case by rival Lundbeck, including orders for damages previously calculated at $26.3 million and counting, despite having succeeded at the High Court in a dispute over its patent for blockbuster antidepressant Lexapro.
Life insurer Select AFSL, director hit with $13M penalty for unconscionable sales tactics
Peru sour after failed bid to trade mark pisco
Dow loses latest spat with Nufarm over patent for low vapour drift herbicide
Layoffs unlikely, but salary slowdown coming for lawyers
Time to end this ‘sorry business’: Court tosses objection to EY settlement
In class action defence, Optus says data breach victims not entitled to damages
Optus has denied class action claims that customers suffered loss and damages for its alleged negligence in relation to last year’s massive data breach and argues they are not entitled to compensation for distress, frustration or disappointment that does not amount to a recognised psychiatric illness.